ニードルフリー糖尿病ケア市場- 世界の産業規模、シェア、動向、機会、予測、デバイスタイプ別、エンドユーザー別、地域別、競合別セグメント、2020-2030年

ニードルフリー糖尿病ケアの世界市場規模は、2024年に135億1,000万米ドルとなり、2030年までのCAGRは5.90％と予測され、予測期間中に大きな成長が見込まれています。

この市場は、糖尿病管理のために従来のインスリン注射法に代わる方法を提供することに重点を置き、糖尿病患者により便利で苦痛の少ない選択肢を提供します。

主な市場促進要因

糖尿病の有病率の上昇

主要市場の課題

規制当局の承認

主要市場動向：規制当局の承認

クローズドループシステム

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界のニードルフリー糖尿病ケア市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • デバイスタイプ別（インスリン注入器、インスリンパッチ、インスリンペン、インスリンポンプ、ジェットインジェクター）
  • エンドユーザー別（在宅ケア、診断センター、病院、クリニック）
  • 地域別
  • 企業別（2024）
• 製品市場マップ
  • デバイスタイプ別
  • エンドユーザー別
  • 地域別

第6章 北米のニードルフリー糖尿病ケア市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州のニードルフリー糖尿病ケア市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン

第8章 アジア太平洋地域のニードルフリー糖尿病ケア市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • 日本
  • インド
  • オーストラリア
  • 韓国

第9章 南米のニードルフリー糖尿病ケア市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカのニードルフリー糖尿病ケア市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 合併と買収
• 製品上市

第13章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第14章 競合情勢

• 3M Co
• Bioject Medical Technologies Inc
• Valeritas Inc
• Antares Pharma Inc
• Endo International PLC
• InsuJet
• Pharmajet Inc
• INJEX Pharma AG
• Johnson & Johnson
• MannKind Corp

第15章 戦略的提言

第16章 調査会社について・免責事項

The global Needle-Free Diabetes Care market was valued at USD 13.51 billion in 2024 and is expected to experience significant growth during the forecast period, with a projected compound annual growth rate (CAGR) of 5.90% through 2030. This market focuses on providing alternatives to traditional insulin injection methods for the management of diabetes, offering more convenient and less painful options for individuals with diabetes.

Key Market Drivers:

Rising Prevalence of Diabetes

The increasing prevalence of diabetes is largely driven by factors such as sedentary lifestyles, poor dietary habits, and an aging population. This growing global health concern not only impacts individual health but also places a substantial strain on healthcare systems and economies. According to the World Health Organization (WHO), diabetes is a chronic condition characterized by elevated blood glucose levels, which can lead to severe complications. Over 830 million people worldwide are affected by diabetes, with a significant proportion living in low- and middle-income countries. Diabetes management is shifting from a physician-centered model to a more patient-centric approach. Patients now seek solutions that offer greater convenience, reduce pain, and improve their quality of life. As traditional insulin injections are often seen as uncomfortable and inconvenient, there is an increasing demand for needle-free alternatives.

Key Market Challenges:

Regulatory Approvals

One of the key challenges in the needle-free diabetes care market is the need for regulatory approvals for new devices and technologies. Regulatory bodies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) impose strict safety and efficacy standards, making the approval process time-consuming and costly for manufacturers. These regulatory hurdles can delay the introduction of new products into the market.

Key Market Trends:

Closed-Loop Systems

Closed-loop insulin delivery systems, often referred to as artificial pancreases, are gaining popularity in the diabetes care market. These systems automatically adjust insulin delivery based on continuous glucose monitoring (CGM) data, providing users with better control over their blood glucose levels. As technology continues to evolve, closed-loop systems are expected to become more accessible, user-friendly, and effective.

Key Market Players:

• 3M Co
• Bioject Medical Technologies Inc
• Valeritas Inc
• Antares Pharma Inc
• Endo International PLC
• InsuJet
• PharmaJet Inc
• INJEX Pharma AG
• Johnson & Johnson
• MannKind Corp

Report Scope:

This report segments the global Needle-Free Diabetes Care market into the following categories, while also providing insights into key industry trends:

By Device Type:

• Insulin Infusers
• Insulin Patches
• Insulin Pens
• Insulin Pumps
• Jet Injectors

By End-User:

• Homecare
• Diagnostic Centers
• Hospitals & Clinics

By Region:

• North America: United States, Canada, Mexico
• Europe: Germany, United Kingdom, France, Italy, Spain
• Asia-Pacific: China, Japan, India, Australia, South Korea
• South America: Brazil, Argentina, Colombia
• Middle East & Africa: South Africa, Saudi Arabia, UAE, Kuwait

Competitive Landscape and Company Profiles:

This section provides an in-depth analysis of the major players operating in the global Needle-Free Diabetes Care market.

Available Customizations:

TechSci Research offers customized reports based on specific market data for the global Needle-Free Diabetes Care market. The following customization options are available:

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Needle Free Diabetes Care Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Device Type (Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps, Jet Injectors)
  • 5.2.2. By End User (Homecare, Diagnostic Center, Hospitals & Clinic)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Product Market Map
  • 5.3.1. By Device Type
  • 5.3.2. By End User
  • 5.3.3. By Region

6. North America Needle Free Diabetes Care Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Device Type (Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps, Jet Injectors)
  • 6.2.2. By End User (Homecare, Diagnostic Center, Hospitals & Clinic)
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Needle Free Diabetes Care Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Device Type
      • 6.3.1.2.2. By End User
  • 6.3.2. Canada Needle Free Diabetes Care Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Device Type
      • 6.3.2.2.2. By End User
  • 6.3.3. Mexico Needle Free Diabetes Care Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Device Type
      • 6.3.3.2.2. By End User

7. Europe Needle Free Diabetes Care Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Device Type (Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps, Jet Injectors)
  • 7.2.2. By End User (Homecare, Diagnostic Center, Hospitals & Clinic)
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Needle Free Diabetes Care Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Device Type
      • 7.3.1.2.2. By End User
  • 7.3.2. United Kingdom Needle Free Diabetes Care Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Device Type
      • 7.3.2.2.2. By End User
  • 7.3.3. France Needle Free Diabetes Care Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Device Type
      • 7.3.3.2.2. By End User
  • 7.3.4. Italy Needle Free Diabetes Care Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Device Type
      • 7.3.4.2.2. By End User
  • 7.3.5. Spain Needle Free Diabetes Care Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Device Type
      • 7.3.5.2.2. By End User

8. Asia-Pacific Needle Free Diabetes Care Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Device Type (Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps, Jet Injectors)
  • 8.2.2. By End User (Homecare, Diagnostic Center, Hospitals & Clinic)
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Needle Free Diabetes Care Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Device Type
      • 8.3.1.2.2. By End User
  • 8.3.2. Japan Needle Free Diabetes Care Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Device Type
      • 8.3.2.2.2. By End User
  • 8.3.3. India Needle Free Diabetes Care Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Device Type
      • 8.3.3.2.2. By End User
  • 8.3.4. Australia Needle Free Diabetes Care Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Device Type
      • 8.3.4.2.2. By End User
  • 8.3.5. South Korea Needle Free Diabetes Care Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Device Type
      • 8.3.5.2.2. By End User

9. South America Needle Free Diabetes Care Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Device Type (Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps, Jet Injectors)
  • 9.2.2. By End User (Homecare, Diagnostic Center, Hospitals & Clinic)
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Needle Free Diabetes Care Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Device Type
      • 9.3.1.2.2. By End User
  • 9.3.2. Argentina Needle Free Diabetes Care Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Device Type
      • 9.3.2.2.2. By End User
  • 9.3.3. Colombia Needle Free Diabetes Care Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Device Type
      • 9.3.3.2.2. By End User

10. Middle East and Africa Needle Free Diabetes Care Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Device Type (Insulin Infuser, Insulin Patches, Insulin Pens, Insulin Pumps, Jet Injectors)
  • 10.2.2. By End User (Homecare, Diagnostic Center, Hospitals & Clinic)
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Needle Free Diabetes Care Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Device Type
      • 10.3.1.2.2. By End User
  • 10.3.2. Saudi Arabia Needle Free Diabetes Care Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Device Type
      • 10.3.2.2.2. By End User
  • 10.3.3. UAE Needle Free Diabetes Care Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Device Type
      • 10.3.3.2.2. By End User
  • 10.3.4. Kuwait Needle Free Diabetes Care Market Outlook
    • 10.3.4.1. Market Size & Forecast
      • 10.3.4.1.1. By Value
    • 10.3.4.2. Market Share & Forecast
      • 10.3.4.2.1. By Device Type
      • 10.3.4.2.2. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. 3M Co
• 14.2. Bioject Medical Technologies Inc
• 14.3. Valeritas Inc
• 14.4. Antares Pharma Inc
• 14.5. Endo International PLC
• 14.6. InsuJet
• 14.7. Pharmajet Inc
• 14.8. INJEX Pharma AG
• 14.9. Johnson & Johnson
• 14.10.MannKind Corp

15. Strategic Recommendations

16. About Us & Disclaimer